Umang Swami
Huntsman Cancer Institute · University of Utah
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Umang Swami as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:53 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07216248 · Optimal PSA Triggered Individual Management of Androgen Sensitive Prostate CancerUniversity of Utah · recruiting · Metastatic Hormone-sensitive Prostate Cancer (mHSPC) · principal investigator
- Ph2NCT06568562 · XL092 in Patients With Metastatic Castration-Resistant Prostate CancerUniversity of Utah · recruiting · Metastatic Castration-resistant Prostate Cancer · principal investigator
- Ph2NCT06029998 · Bortezomib in Patients With Metastatic Castration-Resistant Prostate Cancer With PTEN DeletionUniversity of Utah · active not recruiting · Metastatic Castration-resistant Prostate Cancer · principal investigator
- Ph1NCT05613894 · Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate CancerUniversity of Utah · recruiting · Metastatic Castration-resistant Prostate Cancer · principal investigator
- Ph2NCT05168618 · Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate CancerUniversity of Utah · active not recruiting · Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 · principal investigator
- Ph2NCT04754191 · Enfortumab Vedotin as Monotherapy in Patients With Metastatic Castration-Resistant Prostate CancerUniversity of Utah · active not recruiting · Metastatic Castration-resistant Prostate Cancer · principal investigator
- Ph1NCT04109729 · Study of Nivolumab in Combination w Radium-223 in Men w Metastatic Castration Resistant Prostate CancerUniversity of Utah · active not recruiting · Metastatic Castration-resistant Prostate Cancer · principal investigator
- Ph2NCT03421782 · Fatigue Interventions in Cancer (Exercise Intervention)University of Utah · completed · Sedentary Lifestyle, Stage III Prostate Cancer AJCC v7, Stage IV Prostate Cancer AJCC v7 · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:53 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Cancer Center Support GrantP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI CORNELIA M ULRICH · fiscal years 2014 to 2026Named on NCT05168618
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:53 UTC. The ranking covers the 200 most relevant of 28 PubMed records, and a shared surname and initials can bring in a namesake. All 28 on PubMed
- 71 citationsRCR 14.8
- 37 citationsRCR 8.0
- Sacituzumab Govitecan Demonstrates Efficacy across Tumor Trop-2 Expression Levels in Patients with Advanced Urothelial Cancer.Clin Cancer Res · 202434 citationsRCR 2.9
- 27 citationsRCR 5.2
- Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results.Oncologist · 202124 citationsRCR 1.1
- 19 citationsRCR 1.9
- 10 citationsRCR 0.3
- Bone Pain and Survival Among Patients With Metastatic, Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG-1216 Trial.JAMA Netw Open · 202410 citationsRCR 1.3
- Experience with vena cava filters at a large community hospital and level-I trauma center: indications, complications, and compliance barriers.Clin Appl Thromb Hemost · 20148 citationsRCR 0.4
- External Validation of Association of Baseline Circulating Tumor Cell Counts with Survival Outcomes in Men with Metastatic Castration-Sensitive Prostate Cancer.Mol Cancer Ther · 20228 citationsRCR 0.5